[1]
Wu, Z. et al. 2026. Clinical features, diagnosis, and outcome of anaplastic lymphoma kinase tyrosine kinase inhibitors associated interstitial lung disease. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 43, 2 (Jun. 2026), 18699. DOI:https://doi.org/10.36141/svdld.2026.18699.